Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BMY
MRK
Add up to 3 more stocks
BMY
Bristol-Myers Squibb Company
-0.17%
$63.64-0.11Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$130.00B
52W Range
$42.52 - $68.64
MRK
Merck & Co., Inc.
-0.54%
$143.94-0.78Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$355.49B
52W Range
$77.58 - $156.92
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 14.02 | 115.15 |
| Forward P/E | 9.18 | 52.41 |
| P/B Ratio | 5.82 | 8.48 |
| P/S Ratio | 2.64 | 5.35 |
| P/FCF Ratio | 11.36 | 22.13 |
| EV/EBITDA | 9.71 | 22.76 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 70.2% | 75.4% |
| Operating Margin | 28.3% | 36.2% |
| Net Margin | 18.9% | 4.8% |
| ROE | 41.6% | 7.6% |
| ROA | 10.6% | 2.4% |
| ROIC | 15.5% | 5.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.53 | 1.32 |
| Quick Ratio | 1.38 | 1.10 |
| Debt/Equity | 1.93 | 1.29 |
| Interest Coverage | 7.26 | 17.31 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 3.9% | 2.3% |
| Payout Ratio | 55.3% | 268.8% |
| Yrs of Dividend Growth | 16 | 15 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.